Home › Funds › Paradigm Biocapital Advisors LP › MANE
Paradigm Biocapital Advisors LP position in MANE
VERADERMICS INC · Health Care
Paradigm Biocapital Advisors LP reported holding 310,060 shares of MANE (VERADERMICS INC) in its Q3 2026 13F filing — a position valued at US$37.6M, representing 0.75% of its reported portfolio and ranking #20 among its reported holdings. Paradigm Biocapital Advisors LP has disclosed MANE holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Paradigm Biocapital Advisors LP's MANE position evolved
Paradigm Biocapital Advisors LP first disclosed a stake in MANE in Q1 2026 at 525,000 shares (US$33.2M). The position peaked in Q3 2026 at 310,060 shares, worth US$37.6M. Across 2 filings, Paradigm Biocapital Advisors LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 310,060 shares valued at US$37.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 525.00K | $33.15M | New |
| Q3 2026 | 310.06K | $37.59M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MANE and 13F data
MANE (VERADERMICS INC) is a Health Care company. 150 other funds we track also report a position in MANE — the largest reported positions include MONTANOVA CAPITAL, LLC (US$512.5M), SR ONE CAPITAL MANAGEMENT, LP (US$295.3M), Deep Track Capital, LP (US$230.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MANE
- MONTANOVA CAPITAL, LLC 4.17M sh · $512.53M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 2.40M sh · $295.29M · Q2 2026
- Deep Track Capital, LP 1.90M sh · $230.34M · Q3 2026
- Siren, L.L.C. 1.32M sh · $160.54M · Q3 2026
- Maverick Capital 789.98K sh · $97.12M · Q2 2026
- MAVERICK CAPITAL LTD 789.98K sh · $97.12M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 731.15K sh · $89.89M · Q2 2026
- EMERALD ADVISERS, LLC 332.39K sh · $40.30M · Q3 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 225.55K sh · $27.34M · Q3 2026
- Logos Global Management LP 170.00K sh · $20.61M · Q3 2026
- Kalehua Capital Management LLC 145.69K sh · $17.66M · Q3 2026
- Sofinnova Investments, Inc. 144.05K sh · $17.46M · Q3 2026
More on Paradigm Biocapital Advisors LP
FAQ
How long has Paradigm Biocapital Advisors LP held MANE?
Paradigm Biocapital Advisors LP has disclosed MANE holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
What is Paradigm Biocapital Advisors LP's current position in MANE?
As of Q3 2026, Paradigm Biocapital Advisors LP holds 310.06K shares of MANE (VERADERMICS INC), valued at $37.59M, representing 0.75% of its reported portfolio and ranking #20.
Has Paradigm Biocapital Advisors LP been buying or selling MANE?
In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP newly opened its position in MANE. The position peaked in Q3 2026 at 310.06K shares.
Which other funds hold MANE?
Other major institutional holders of MANE include MONTANOVA CAPITAL, LLC, SR ONE CAPITAL MANAGEMENT, LP, Deep Track Capital, LP, among 150 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.